eBOOK | OCT 30, 2025
ESMO 2025 Highlights are Here!
The Scrip ESMO 2025 eBook brings together expert analysis, strategic implications, and actionable data from this important oncology event.
With exclusive interviews and commentary from Scrip journalists and industry leaders, this exclusive collection is your essential guide to the latest advances from the European Society for Medical Oncology congress in Berlin.
Download your free copy now and join thousands of industry professionals who rely on Scrip for daily insights.
What's inside?
- Next-generation therapies: Discover how antibody-drug conjugates like Enhertu are redefining early-stage breast cancer treatment.
- Competitive insights: Explore the race in triple-negative breast cancer, with Trodelvy and Datroway emerging as first-line options.
- Breakthroughs in prostate, ovarian, and bladder cancer: Learn about Novartis’s Pluvicto, Merck & Co’s advances in platinum-resistant ovarian cancer, and the Padcev/Keytruda combination that’s halved the risk of death in bladder cancer trials.
Our recent awards

